Nitric Oxide Therapy Devices and Supply

Cook County Health has issued a Request for Proposal (RFP No. H25-25-150) seeking a vendor to provide pharmaceutical grade nitric oxide therapy devices and comprehensive support services for Stroger Hospital. The procurement specifically requires at least three inhalation devices capable of serving both adult and neonatal patients experiencing pulmonary hypertension or compromised oxygenation. The devices must be UL or CSU certified, compact enough for ambulance transport, and able to deliver uninterrupted gas. Proposers are required to submit electronic proposals by November 17, 2025, at 2:00 PM Central Time through the Cook County Health Bonfire portal. The successful vendor will be responsible for providing pharmaceutical grade nitric oxide, all necessary consumables, maintenance services, emergency backup devices, and staff training. Evaluation criteria will include the proposer's ability to meet CCH's business goals, relevant experience, implementation approach, and overall pricing. Proposers must submit comprehensive documentation, including a cover letter, executive summary, qualifications, references, key personnel details, and a detailed plan of action.

The procurement includes specific Minority and Women Business Enterprise (MBE/WBE) participation goals, with targets of 9.57% MBE and 8.90% WBE participation. Proposers must complete detailed MBE/WBE documentation, including Utilization Plan forms, Letters of Intent, and potential Waivers of Participation. The contract will require comprehensive compliance with various county regulations, including the Human Rights Ordinance, Gift Ban Ordinance, and Living Wage Ordinance. Vendors must complete an Economic Disclosure Statement detailing business ownership, familial relationships, and potential conflicts of interest. While specific contract value is not explicitly stated in the documents, the procurement appears to be structured for a three-year term with potential for renewal. Proposers will be required to provide audited financial statements and may be subject to site visits, presentations, or requests for additional information. The final contract will be subject to review and approval by CCH management, legal team, and Board of Directors.